[go: up one dir, main page]

PL2178533T3 - Kompozycja przeciwwirusowa zawierająca siarczanowany polisacharyd: jota-karagen - Google Patents

Kompozycja przeciwwirusowa zawierająca siarczanowany polisacharyd: jota-karagen

Info

Publication number
PL2178533T3
PL2178533T3 PL08785672T PL08785672T PL2178533T3 PL 2178533 T3 PL2178533 T3 PL 2178533T3 PL 08785672 T PL08785672 T PL 08785672T PL 08785672 T PL08785672 T PL 08785672T PL 2178533 T3 PL2178533 T3 PL 2178533T3
Authority
PL
Poland
Prior art keywords
iota
carrageenan
sulfated polysaccharide
antiviral composition
antiviral
Prior art date
Application number
PL08785672T
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of PL2178533T3 publication Critical patent/PL2178533T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL08785672T 2007-08-24 2008-08-22 Kompozycja przeciwwirusowa zawierająca siarczanowany polisacharyd: jota-karagen PL2178533T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93566807P 2007-08-24 2007-08-24
PCT/EP2008/006910 WO2009027057A1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide
EP08785672A EP2178533B1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide: iota-carrageenan

Publications (1)

Publication Number Publication Date
PL2178533T3 true PL2178533T3 (pl) 2013-08-30

Family

ID=40198591

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08785672T PL2178533T3 (pl) 2007-08-24 2008-08-22 Kompozycja przeciwwirusowa zawierająca siarczanowany polisacharyd: jota-karagen

Country Status (26)

Country Link
US (2) US20110059919A1 (pl)
EP (1) EP2178533B1 (pl)
JP (1) JP5647518B2 (pl)
KR (1) KR101571571B1 (pl)
CN (1) CN101784272B (pl)
AP (1) AP2630A (pl)
BR (1) BRPI0815748B8 (pl)
CA (1) CA2696009C (pl)
CY (1) CY1113949T1 (pl)
DK (1) DK2178533T3 (pl)
EA (1) EA018138B1 (pl)
ES (1) ES2406684T3 (pl)
HR (1) HRP20130402T1 (pl)
IL (1) IL203444A (pl)
MA (1) MA31748B1 (pl)
MX (1) MX2010001986A (pl)
MY (1) MY153900A (pl)
NO (1) NO20100097L (pl)
NZ (1) NZ583511A (pl)
PL (1) PL2178533T3 (pl)
PT (1) PT2178533E (pl)
SI (1) SI2178533T1 (pl)
TN (1) TN2010000086A1 (pl)
UA (1) UA102673C2 (pl)
WO (1) WO2009027057A1 (pl)
ZA (1) ZA201000951B (pl)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884024B2 (en) * 2005-12-27 2018-02-06 Hemant N Joshi Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
ES2445870T3 (es) * 2008-07-01 2014-03-05 Marinomed Biotechnologie Gmbh Biopolímeros antialérgicos marinos
EP2381951B1 (en) * 2009-01-28 2015-12-23 Life Science Nutrition AS Compositions and methods of treating viral infections
JP2010248105A (ja) * 2009-04-14 2010-11-04 Bio Plan:Kk ウイルス感染阻害用組成物
DK2515889T3 (en) 2009-12-22 2015-03-02 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
JP2011168533A (ja) * 2010-02-18 2011-09-01 Kyosei Seiyaku Kk 抗インフルエンザウイルス剤
EP2538946B1 (en) * 2010-02-22 2022-04-06 Marinova Pty Ltd Anti-viral formulations
CN101869110B (zh) * 2010-07-14 2013-03-13 山东圣鹏农药有限公司 一种抗植物病毒病组合物及其应用
WO2012018628A1 (en) 2010-07-26 2012-02-09 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
FR2969926B1 (fr) * 2011-01-04 2017-03-10 Elicityl Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2012126777A1 (en) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
WO2012138885A1 (en) * 2011-04-05 2012-10-11 Knocean Sciences, Inc Macrocystis pyrifera derived health and wellness products and methods of using the same
WO2013006795A2 (en) * 2011-07-07 2013-01-10 Humanitas International Foundation Antiviral compositions and methods of their use
CN102764266A (zh) * 2012-07-30 2012-11-07 吉林省辉南长龙生化药业股份有限公司 褐藻多糖硫酸酯在制备预防和治疗慢性阻塞性肺病药物中的用途
CN102988409A (zh) * 2012-11-26 2013-03-27 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗重症肝炎药物中的应用
US9974850B2 (en) 2013-01-25 2018-05-22 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
NZ710602A (en) 2013-01-25 2020-01-31 Marinova Pty Ltd Methods for reducing pyrogenicity in a seaweed extract
CN103301065A (zh) * 2013-06-27 2013-09-18 辽宁亿灵科创生物医药科技有限公司 一种海藻提取物的鼻喷剂及其制备方法
ES2753218T5 (en) 2013-12-03 2025-02-17 Gerolymatos Int S A Ionic aqueous compositions
HUE044329T2 (hu) 2014-01-22 2019-10-28 Visufarma B V Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen
CN104721221B (zh) * 2015-01-29 2017-08-04 广州暨南生物医药研究开发基地有限公司 琼枝麒麟菜多糖用于制备抗呼吸道病毒药物中的用途
US10660914B2 (en) * 2015-07-14 2020-05-26 Marinomed Biotech Ag Stuffy nose deblocking composition having antiviral activity
US10434119B2 (en) * 2016-01-13 2019-10-08 Gargle Water, Inc. Pharyngeal or buccal cavity rinse and process of use thereof
CN117942405A (zh) 2016-02-25 2024-04-30 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
US12447166B2 (en) * 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
CN106309470B (zh) * 2016-08-30 2021-05-18 闫滨 一种羊栖菜多糖的应用
US11045519B2 (en) 2017-01-31 2021-06-29 Unm Rainforest Innovations Arginine-rich polypeptide compositions and methods of using same
JP7261367B2 (ja) * 2018-02-14 2023-04-20 江南化工株式会社 抗ウイルス剤及び抗ウイルス組成物
JP6942350B2 (ja) * 2018-04-26 2021-09-29 江南化工株式会社 抗ウイルス剤及び抗ウイルス用組成物
WO2020006494A1 (en) 2018-06-29 2020-01-02 Fred Hutchinson Cancer Research Center Cell-stored barcoded deep mutational scanning libraries and uses of the same
US12186334B2 (en) * 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
EP3870139A1 (en) * 2018-11-27 2021-09-01 Colgate-Palmolive Company Multi-benefit personal care compositions and methods for the same
GB2579600B (en) 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN112137953A (zh) * 2019-06-26 2020-12-29 山东百骏生物科技有限公司 一种用于感冒辅助治疗的液体敷料
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same
WO2021168173A1 (en) * 2020-02-20 2021-08-26 Synkine Therapeutics, Inc. Methods and compositions for treating viral respiratory infections
CN115209954B (zh) * 2020-03-09 2024-04-30 生物组织再生和修复公司 用于治疗呼吸系统病变的组合物
CA3171235A1 (en) * 2020-03-12 2021-09-16 Sydney David Cullis-Hill Treatment for coronavirus infection and associated cytokine toxicity
WO2021191904A1 (en) * 2020-03-26 2021-09-30 Tree Of Life Pharma Ltd. Methods for preventing and treating viral infection
US20230201249A1 (en) * 2020-04-02 2023-06-29 Linhardt Robert John Compositions incorporating sulfated polysaccharides for inhibiting sars-cov-2
NL2025335B1 (en) 2020-04-10 2021-10-26 Logick Energetics B V Pharmaceutical composition for treatment of corona virus infection
CN111471088B (zh) * 2020-04-21 2021-02-09 北京中科微盾生物科技有限责任公司 一种抑制sars-cov-2感染的多肽、组合物及其用途
CN111686125A (zh) * 2020-06-18 2020-09-22 大连工业大学 卡拉胶在抗新型冠状病毒中的应用
WO2021253643A1 (zh) * 2020-06-18 2021-12-23 大连工业大学 硫酸化多糖在抗新型冠状病毒中的应用
EP3932412A1 (en) 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Antiviral pharmaceutical composition
EP3932411A1 (en) 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Antiviral pharmaceutical composition
EP3939597A1 (en) * 2020-07-16 2022-01-19 Marinomed Biotech AG Antiviral pharmaceutical composition comprising a carrageenan component
CN114053251A (zh) * 2020-07-29 2022-02-18 苏州融析生物科技有限公司 硫酸化多糖吸入制剂及其在防治新冠病毒相关疾病中的应用
JP2023539940A (ja) 2020-09-08 2023-09-20 アルタミラ メディカ， アーゲー 感染を防止するための組成物
CN112220799A (zh) * 2020-11-02 2021-01-15 江苏泰德医药有限公司 一种抑制病毒的产品及用途
WO2022131283A1 (ja) * 2020-12-15 2022-06-23 正一 中村 海藻類及びその抽出物を含有する食品類及び飲料水類
WO2022131282A1 (ja) * 2020-12-15 2022-06-23 正一 中村 海藻類及びその抽出物を含有するせっけん類、消毒剤、殺菌剤及び洗浄剤
EP4079289A1 (en) 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Anti-viral composition for administration into nose, mouth or throat
EP4079300A1 (en) 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Anti-viral composition for administration into nose, mouth or throat
GB202109888D0 (en) 2021-07-08 2021-08-25 Pollinner Ltd Nasal spray
EP4130258A1 (en) 2021-08-02 2023-02-08 Evonik Operations GmbH Microorganisms displaying viral decoy receptors
IL318697A (en) * 2021-08-31 2025-03-01 Polyrizon Ltd Mucoadhesive polymers for drug release in nasal tissue
CN114264530B (zh) * 2021-12-30 2023-05-05 重庆市畜牧科学院 一种基于Avicel的病毒蚀斑测定方法及其应用
CN114395538A (zh) * 2022-01-19 2022-04-26 和元生物技术（上海）股份有限公司 一种促进重组病毒载体向细胞外分泌的方法
WO2025067689A1 (en) 2023-09-26 2025-04-03 Metriopharm Ag 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
CH680265A5 (en) * 1990-06-25 1992-07-31 Madeleine Luescher Mattli Dr Polyanionic cpds. for treatment of myxo- and para-myxo-virus diseases - effective against e.g. influenza, measles, mumps and distemper and use e.g. a sulphonated polysaccharide
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
EP0678030A1 (en) * 1993-01-08 1995-10-25 The Population Council Use of sulphated polysaccharides for preventing sexually transmitted diseases
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
ATE227571T1 (de) 1996-08-12 2002-11-15 Merck & Co Inc Thrombin inhibitoren
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
JPH1180003A (ja) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd 感染症予防・治療剤
DE19961307A1 (de) 1999-12-18 2001-07-12 Krewel Meuselbach Gmbh Medizinprodukt zur Befeuchtung und Reinigung der Nasenschleimhaut
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤
FR2808687B1 (fr) 2000-04-27 2003-12-05 Goemar Lab Sa Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
ES2253395T3 (es) 2000-06-30 2006-06-01 Polydex Pharmaceuticals Limited Uso de sulfato de celulosa y otros polisacaridos sulfatados para prevenir y tratar infecciones por virus del papiloma.
DE10051955A1 (de) * 2000-10-20 2002-05-02 Wella Ag Haarbehandlungsmittel in Form eines festen und formstabilen Gels
JP2003081841A (ja) 2001-06-26 2003-03-19 Kikkoman Corp 抗アレルギー体質強化剤
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
TW200500085A (en) * 2003-02-26 2005-01-01 Otsuka Pharma Co Ltd Sustained-release pharmaceutical composition for lung administration
WO2005004882A1 (en) 2003-07-09 2005-01-20 Monash University Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US20080004236A1 (en) 2004-02-06 2008-01-03 Comper Wayne D High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
US20080184618A1 (en) * 2005-08-03 2008-08-07 Amcol International Virus-Interacting Layered Phyllosilicates and Methods of Use
US20080241271A1 (en) * 2006-11-08 2008-10-02 Roman Stephen B Foaming anti-adhesion composition

Also Published As

Publication number Publication date
WO2009027057A1 (en) 2009-03-05
EA201070299A1 (ru) 2010-08-30
PT2178533E (pt) 2013-06-03
UA102673C2 (ru) 2013-08-12
KR20100045468A (ko) 2010-05-03
EA018138B1 (ru) 2013-05-30
IL203444A (en) 2015-05-31
BRPI0815748B8 (pt) 2021-05-25
TN2010000086A1 (en) 2011-09-26
MA31748B1 (fr) 2010-10-01
BRPI0815748B1 (pt) 2019-04-24
JP2011512319A (ja) 2011-04-21
CY1113949T1 (el) 2016-07-27
NZ583511A (en) 2012-02-24
SI2178533T1 (sl) 2013-07-31
ES2406684T3 (es) 2013-06-07
HK1144558A1 (en) 2011-02-25
DK2178533T3 (da) 2013-05-27
CA2696009A1 (en) 2009-03-05
HRP20130402T1 (hr) 2013-06-30
JP5647518B2 (ja) 2014-12-24
BRPI0815748A2 (pt) 2015-02-18
US20120237572A1 (en) 2012-09-20
ZA201000951B (en) 2011-04-28
EP2178533B1 (en) 2013-03-27
CN101784272B (zh) 2014-03-12
US10342820B2 (en) 2019-07-09
CA2696009C (en) 2016-08-02
AP2630A (en) 2013-03-28
CN101784272A (zh) 2010-07-21
AU2008291290A1 (en) 2009-03-05
EP2178533A1 (en) 2010-04-28
AP2010005170A0 (en) 2010-02-28
MY153900A (en) 2015-04-15
US20110059919A1 (en) 2011-03-10
MX2010001986A (es) 2010-03-11
NO20100097L (no) 2010-03-24
KR101571571B1 (ko) 2015-11-24

Similar Documents

Publication Publication Date Title
PL2178533T3 (pl) Kompozycja przeciwwirusowa zawierająca siarczanowany polisacharyd: jota-karagen
ZA201003041B (en) Chitosan composition
IL194489A0 (en) Bifunctionalized polysaccharides
IL205143A (en) Sulphate oligosaccharides
PL2011816T4 (pl) Ko-sieciowany żel polisacharydowy
SI2303930T1 (sl) Sulfatirana polisaharidna spojina in priprava ter uporaba le-te
GB0707006D0 (en) Turbine
GB0712234D0 (en) Pasteurising solar still
EP2110103A4 (en) STENT
EP1978056A4 (en) HYDROXYALKYLATED CHITOSAN-INCLUDING SOLUTION
SI2309878T1 (sl) Dietetična odvajala
GB0803707D0 (en) Antiviral agent
EP2087798A4 (en) BALLASTIC COMPOSITION CONTAINING POLYSACCHARIDE THICKENERS
GB0613952D0 (en) Antiviral agent
GB2448333B (en) Turbine
GB0723609D0 (en) Antiviral
GB0724579D0 (en) Waterwheel
GB2439046B (en) Antiviral product
GB0721935D0 (en) New Carbohydrate derivatives
GB0724539D0 (en) Polysaccharides
GB0720760D0 (en) Improvement in or relating to arms
GB0610681D0 (en) Improvements in relation to stepladders
GB0702311D0 (en) Multiple extension to sudoko
GB0713347D0 (en) Cascade solar still
GB0707227D0 (en) Patent application number two